Latest cardiovascular News | Page 19

Heart Research Institute awards grants for NZ collaborations
$21.8 million to turn medical research into better patient care 17 January
Australians are living longer from lockdowns
Huge funding boost to launch Australia’s first collaborative cardiovascular research accelerator
New funding for better heart health in Aboriginal and Torres Strait Islander communities
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
AstraZeneca and Scorpion Therapeutics enter agreement to discover, develop and commercialise novel cancer treatments against
Citizen science helps nurture our health through nature
Link between burn injuries and cardiovascular disease explored
How do effects of childhood abuse extend into middle age?
Audit finds surgery remains safe in Victoria despite significant decrease in presentations due to Covid
Machine learning illuminates genetic links between blood cells and disease
New Study Reveals Heart Disease Triggered by Complex Networks of Genes
Older Australians beat heat at home
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Arterial Inflammation and Redox Biology Group publishes in Nature Communications
Transfer of global rights for Eklira and Duaklir to Covis Pharma completed
Heart monitor, ‘tinder for musicians’ win Big Ideas Competition
New study could inform treatment and prevent heart attack in diabetic patients
AstraZeneca and Ionis close agreement to develop and commercialise eplontersen
Covid patients have severely increased levels of oxidative stress and oxidant damage, and glutathione deficiency
Vaxzevria significantly boosted antibody levels against Omicron
New discovery to aid treatment of problem infant hemangiomas
Assange Stroke: 300+ Doctors Urge Aust. Deputy PM to Intervene
Ultomiris regulatory submission accepted under FDA Priority Review
New insight into molecular mechanisms underlying development of heart failure
Black summer bushfires of 2019-20 led to huge health burden in NSW, study finds
Tezspire approved in US for severe asthma
Heart Research Institute wins Silver in PRIA Golden Target Awards
Evusheld long-acting antibody combination retains neutralising activity against Omicron variant
Common sleep disorder combo could be deadly
Poor social health predictor for cardiovascular disease
UN rights expert laments adverse impact of industrialisation, urges measures to redress damage: Italy
Telehealth to stay
Investing 1 dollar per person per year could save 7 million lives in low and lower-middle income countries
Preventive policy charts path to healthier future
Why an avo toast may be key to healthy life
How to prevent and recover from sports injuries
Calquence reduced risk of disease progression or death by 71% vs. standard of care combinations
World-first bushfire hazard detection system aiming to save lives, property and environment
HRI hosts two days of premier cardiovascular research
Evusheld long-acting antibody combination authorised for emergency use
Evenings with Genetics addresses genetic testing and heart disease
Life and work experiences of Australians with chronic conditions
Millions in health savings
AstraZeneca and Ionis sign deal to develop and commercialise eplontersen
Daily dose of yoghurt could be go-to food to manage high blood pressure
You cannot be what you cannot see: why medical mentoring matters